1. Home
  2. HOWL vs SRTS Comparison

HOWL vs SRTS Comparison

Compare HOWL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

SELL

Current Price

$0.94

Market Cap

46.7M

Sector

Health Care

ML Signal

SELL

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$2.31

Market Cap

45.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOWL
SRTS
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.7M
45.6M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
HOWL
SRTS
Price
$0.94
$2.31
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.00
★ $5.25
AVG Volume (30 Days)
405.8K
★ 556.2K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 18.40
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $27,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$34.18
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.27
$2.14
52 Week High
$1.20
$5.49

Technical Indicators

Market Signals
Indicator
HOWL
SRTS
Relative Strength Index (RSI) 41.24 35.18
Support Level $0.88 N/A
Resistance Level $0.99 $3.35
Average True Range (ATR) 0.06 0.54
MACD -0.01 -0.09
Stochastic Oscillator 0.00 3.38

Price Performance

Historical Comparison
HOWL
SRTS

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: